Abstract

Abstract Submission is now closed. Thank you for your submissions!

Please note that only abstracts reporting novel clinical trials or major new findings will be considered during this phase.
Late-Breaking Abstracts are intended for highly innovative and time-sensitive research that was not available at the time of the regular abstract deadline.

Late-Breaking submission includes the following categories:

Major Study
Smaller Study / Randomized Clinical Trial
Multi-center Observational Study or Registry
Secondary Analysis of Major Clinical Trials
Investigator Initiated Study

In cases where a clinical trial is still ongoing and results are expected to be available by the time of the Congress, but not yet at the time of Late-Breaking Abstract submission, authors are requested to contact the Programme Committee for further guidance.

Thank you very much for your interest in submitting an abstract for the 35th European Meeting on Hypertension and Cardiovascular Protection – ESH 2026, Gdańsk, Poland.

The abstract submission is now closed.
We sincerely appreciate all authors who submitted their work and contributed to the scientific excellence of the meeting.

All submitted abstracts will undergo review by the Scientific Committee. Corresponding authors will be notified by email regarding acceptance decisions and next steps. Please ensure that the email provided during the abstract submission is accurate as all correspondences will be sent via email.

For further information on the meeting programme, registration, and important congress updates, please visit the relevant sections of the website.

Before preparing and typing your abstract, please carefully read the following instructions:

INSTRUCTIONS FOR ABSTRACT SUBMISSION

Abstracts can only be submitted via the online Abstract Submission Service. Abstracts sent by email will not be accepted
Abstracts must be in English
The deadline for abstract submission is midnight Central European Time on February 27, 2026. Abstracts submitted after this date will not be accepted
The complete abstract must not exceed 180 characters for the TITLE and 340 words / 2800 characters for the BODY
Type the text, including tables and figures, in single-line spacing and using Times New Roman 11. Do not use smaller type.
TITLE: capitalize the entire title. Spell out words. Do not use abbreviations and verify that your title is complete in case you copy and paste it into the field
AUTHORS/AFFILIATIONS: you may enter up to 20 authors in the authors list and 10 affiliations. The presenter must be part of the authors’ list included in the submitted abstract. The names of authors will be published as listed on the submission form. Please ensure you have enter the full list of authors. The authors’ order and details (names, cities, country codes) will be published as entered in the form
TEXT: begin the text on a new line. The text should be arranged using the following headings: objective, design and method, results and conclusions
Do not include authors, institutions, city names or abbreviations in the title or in the text since the grading and selection process is blinded
Do not include grant acknowledgements in the abstract content. Do not cite keywords or references in the abstract, as they are not allowed and will be deleted
Abstract will be accepted based on scientific merit
ESH 2026 allows the submission of abstracts for original contributions to the field only.

The final selection of abstracts will be made by the Scientific Committee by end of February 2026.
All corresponding authors of abstracts will be then notified about the outcome (accepted or not accepted) of the review process.
Please ensure that the email provided during the abstract submission is accurate as all correspondences will be sent via email.

Title

Subtitle

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Important notes:

subtitle

Registration is mandatory to present an abstract during the Meeting. Failure to register will lead to the withdrawal of the abstract from the Meeting Programme and Publication from the Abstract Book.
Each presenting Author is allowed to present up to 2 abstracts with a single paid registration
Presenting Authors of accepted abstracts are entitled to a special registration fee
If the presenting Author has been awarded a grant, paid registration is not required